Crombez Eric Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$493,758.64

Insider Activity of Crombez Eric

According to the SEC Form 4 filings, Crombez Eric, being in a position of

  1. director at Abeona Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 42427 shares for $227,531,
    over all time since 2025-08-14, has bought 0 shares, and sold 47145 shares for $260,214.

Biography of Crombez Eric

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$396,3794100

Comparison of Insiders on Amount of Buys and Sells

2026-05-15SaleAbeona Therapeutics Inc.
ABEO
director
26,143
0.0453%
$5.53$144,636+3.46%
2026-05-05SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
344
0.0003%
$24.96$8,586-0.52%
2026-03-02SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
7,029
0.0071%
$22.80$160,261+3%
2026-02-02SaleAbeona Therapeutics Inc.
ABEO
director
16,284
0.0296%
$5.09$82,895+5.32%
2025-08-14SaleAbeona Therapeutics Inc.
ABEO
director
4,718
0.0088%
$6.93$32,683-25.59%
2025-05-05SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
520
0.0006%
$39.24$20,405-24.08%
2025-04-21SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
242
0.0003%
$35.11$8,497-15.03%
2025-03-03SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
8,945
0.0099%
$42.10$376,585-20.43%
2024-05-02SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
354
0.0004%
$43.66$15,456+1.16%
2024-04-18SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
142
0.0002%
$44.10$6,262+1.15%
2024-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
1,238
0.0015%
$53.76$66,555-15.68%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.